@article{3118c2c69c1a4a73ba83d4aa3ee3a306,
title = "The role of F18-fluorodeoxyglucose positron emission tomography in guiding diagnosis and management in patients with known or suspected cardiac sarcoidosis",
abstract = "Cardiac sarcoidosis (CS) has gained significant interest in recent years with the emergence of advanced imaging modalities such as MRI and F 18-fluorodeoxyglucose-positron emission tomography (FDG-PET) as modalities to aid in the diagnosis of this condition. CS remains a difficult condition to diagnose, particularly in cases of isolated cardiac involvement and it can present with a broad spectrum of clinical syndromes. Furthermore, the appropriate management of these patients remains controversial. FDG-PET has a potential role not only in diagnosis of CS but also in directing further therapies, facilitating the decision to start immunosuppression and monitoring the response to it. In this article, we discuss when to consider FDG-PET, outline the current optimal patient preparation and scanning protocols and then, using case examples, discuss the use of FDG-PET in follow-up of patients with known or suspected CS. We also outline how PET can influence management decisions in these patients.",
keywords = "Fluorodeoxyglucose (FDG), inflammation, metabolism: PET",
author = "{Mc Ardle}, {B. A.} and E. Leung and H. Ohira and Cocker, {M. S.} and Dekemp, {R. A.} and J. Dasilva and D. Birnie and Beanlands, {R. S.} and Nery, {P. B.}",
note = "Funding Information: RSB and RdK are consultants with Jubilant DRAXImage and have received grant funding from a government/industry program (partners: GE Healthcare, Nordion, Lantheus Medical Imaging, DRAXImage). RdK receives revenues from a Rubidium-82 generator technology licensed to Jubilant DRAX-Image, and from sales of FlowQuant. RSB is a consultant for Lantheus Medical Imaging. Funding Information: This work was partially supported by IMAGE-HF (Imaging Modalities to Assist with Guiding Therapy and the Evaluation of Patients with Heart Failure) (Canadian Institute of Health Research team grant # CIF 99470). RB is a career investigator supported by the Heart and Stroke Foundation of Ontario and Tier 1 Research Chair supported by the University of Ottawa. B.M. was supported in part by the MFI HSFO Program Grant (#PRG6242) and The University of Ottawa Heart Institute{\textquoteright}s Whit & Heather Tucker Endowed Research Fellowship in Cardiology Award. Copyright: Copyright 2013 Elsevier B.V., All rights reserved.",
year = "2013",
month = apr,
doi = "10.1007/s12350-012-9668-9",
language = "English (US)",
volume = "20",
pages = "297--306",
journal = "Journal of Nuclear Cardiology",
issn = "1071-3581",
publisher = "Springer New York",
number = "2",
}